Cargando…

The Prognostic Value of Deficient Mismatch Repair in Stage II–IVa Nasopharyngeal Carcinoma in the Era of IMRT

In the era of intensity-modulated radiotherapy (IMRT), it is important to analyse the prognostic value of deficient mismatch repair (dMMR) in nasopharyngeal carcinoma (NPC). In this study, in pretreatment biopsies of 69 patients with stage II–IVa NPC, the expression levels of MMR proteins, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fang-ming, Zhang, Yun-xiang, Li, Xiu-feng, Gao, Jian-fang, Ma, Hao, Wang, Xiao-li, Li, Yang, Li, Cheng, Zhang, Ya-nan, Zhang, Ya-ting, Kan, Hong-xing, Li, Han, Zhang, Shi-geng, Hao, Fu-rong, Wang, Ming-chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298002/ https://www.ncbi.nlm.nih.gov/pubmed/32546739 http://dx.doi.org/10.1038/s41598-020-66678-3

Ejemplares similares

Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques
por: Hwang, Chung-Feng, et al.
Publicado: (2015)

Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era
por: He, Tao, et al.
Publicado: (2021)

A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma
por: Yang, Kaixuan, et al.
Publicado: (2021)

Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study
por: Wu, Xin, et al.
Publicado: (2016)

Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy
por: Li, An-Chuan, et al.
Publicado: (2015)

Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era
por: Kong, Lin, et al.
Publicado: (2016)

Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era
por: Zhang, Lu-Lu, et al.
Publicado: (2017)

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
por: Guo, Shan-Shan, et al.
Publicado: (2018)

The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
por: Jin, Ya-Nan, et al.
Publicado: (2019)

Low-Dimensional Nanomaterial Systems Formed by IVA Group Elements Allow Energy Conversion Materials to Flourish
por: Li, Dan, et al.
Publicado: (2022)

The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT
por: Xu, Tingting, et al.
Publicado: (2016)

Computed Tomography Features of Gastric Cancer Patients With DNA Mismatch Repair Deficiency
por: Cao, Qian, et al.
Publicado: (2021)

A Hybrid IMRT/VMAT Technique for the Treatment of Nasopharyngeal Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

The role of DNA mismatch repair in immunotherapy of human cancer
por: He, Yuchen, et al.
Publicado: (2022)

Mismatch repair status and high expression of PD-L1 in nasopharyngeal carcinoma
por: Zhao, Liang, et al.
Publicado: (2019)

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
por: Ding, Xing-Chen, et al.
Publicado: (2019)

Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
por: Zhang, Cong-Min, et al.
Publicado: (2016)

Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT)
por: Jin, Ya-bin, et al.
Publicado: (2017)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
por: Peng, Hao, et al.
Publicado: (2021)

Simultaneous dose distribution and fluence prediction for nasopharyngeal carcinoma IMRT
por: Li, Yongbao, et al.
Publicado: (2023)

Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement
por: FEN, XINGLAI, et al.
Publicado: (2013)

Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma
por: Lan, Xiao-Wen, et al.
Publicado: (2016)

The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer
por: Fang, Bangwei, et al.
Publicado: (2023)

Structure–Function Decoupling: A Novel Perspective for Understanding the Radiation-Induced Brain Injury in Patients With Nasopharyngeal Carcinoma
por: Kang, Ya-fei, et al.
Publicado: (2022)

Expression of human DNA mismatch-repair protein, hMSH2, in patients with oral lichen planus
por: LI, HAO-BO, et al.
Publicado: (2015)

Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China
por: Liang, Shao-Bo, et al.
Publicado: (2017)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

Microsatellite stability and mismatch repair proficiency in nasopharyngeal carcinoma may not predict programmed death-1 blockade resistance
por: Liao, Xiyi, et al.
Publicado: (2017)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Influence of beamlet width on dynamic IMRT plan quality in nasopharyngeal carcinoma
por: Wu, Manya, et al.
Publicado: (2022)

Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies
por: Li, Ying-Jie, et al.
Publicado: (2023)

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Study
por: OuYang, Pu-Yun, et al.
Publicado: (2016)

Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients
por: Xiao, Youping, et al.
Publicado: (2015)

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
por: Zhong, Qiulu, et al.
Publicado: (2023)

Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT
por: Fan, Xigang, et al.
Publicado: (2022)

Prevalence and spectrum of DNA mismatch repair gene variation in the general Chinese population
por: Zhang, Li, et al.
Publicado: (2022)

The Effect of Magnetic Resonance Imaging Based Radiomics Models in Discriminating stage I–II and III–IVa Nasopharyngeal Carcinoma
por: Li, Quanjiang, et al.
Publicado: (2023)

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
por: Wensink, G. Emerens, et al.
Publicado: (2020)

Phase I/II study of induction chemotherapy plus concurrent chemotherapy and SMART-IMRT-based radiotherapy in locoregionally-advanced nasopharyngeal cancer
por: FAN, TING-YONG, et al.
Publicado: (2013)

Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China
por: Zang, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tf0grhsbdmn225n1b5r6bi9doa